In a pivotal move, the US Food and Drug Administration said Monday that it is taking steps to remove the lengthy “black box” warning on many hormone treatments for women with menopause symptoms, a ...

Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, the Food and Drug Administration announced Monday. In the ...

The US Food and Drug Administration plans to make changes soon to the lengthy black box warning on many hormone replacement products for women with menopause symptoms, Commissioner Dr. Martin Makary ...

For the past decade, Dr. Heather Hirsch has tried to convince women that hormone therapy drugs are the best way to treat symptoms of menopause and perimenopause. But warning labels on estrogen have ...

The lengthy black box warning on menopause treatments is undergoing some changes. Research published in 2002 had shown that menopause hormone therapy carried a risk of cancer and other serious ...

Nov. 10 (UPI) --The Food and Drug Administration announced Monday it would remove the black box warning on hormone replacement therapy for women. Health and Human Services Secretary Robert F. Kennedy ...

When obstetrician JoAnn Pinkerton spoke on a Food and Drug Administration panel recently, she didn't mince words. "Please stop harming women," she said. Pinkerton argues that the FDA's black box ...

For more than 20 years, menopausal hormone therapy carried the U.S. Food and Drug Administration’s (FDA) most serious safety notice: a black box warning that linked treatment to increased risk of ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...